Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Can i take eliquis and tylenol pm together?

See the DrugPatentWatch profile for eliquis

Can you take Eliquis (apixaban) and Tylenol PM together?

Usually, yes. Eliquis (apixaban) works as a blood thinner to reduce clotting risk, while Tylenol PM is acetaminophen (Tylenol) plus an antihistamine (often diphenhydramine). Acetaminophen does not meaningfully increase bleeding risk with apixaban in the way that NSAIDs (like ibuprofen/naproxen) can.

That said, Tylenol PM contains an antihistamine that can cause drowsiness and may increase fall risk, which matters for someone on a blood thinner.

What’s the safest choice if you’re on Eliquis?

If you need pain relief or a sleep aid, many people on Eliquis use plain acetaminophen (Tylenol) rather than “PM” formulations. Plain acetaminophen has the same core pain/fever effect without the added sedating antihistamine.

If you do use Tylenol PM, avoid combining it with other sedatives and be extra cautious with driving or anything that could lead to a fall.

What Tylenol PM ingredients could be a problem?

The apixaban interaction concern is mainly bleeding risk. Acetaminophen is generally considered safe with Eliquis, but:
- The antihistamine (commonly diphenhydramine) can cause sedation and dizziness, increasing the chance of injury if you fall.
- Any product labeling variations (different “PM” versions, different doses) can matter, so it’s best to check the exact active ingredients on your bottle.

How much acetaminophen is safe with Eliquis?

Keeping total acetaminophen within recommended daily limits is important for liver safety. Also avoid accidentally doubling up, since many cold/flu products contain acetaminophen.

If you tell me the exact Tylenol PM product name (mg of acetaminophen and whether it includes diphenhydramine) and your Eliquis dose, I can help you check whether you’re staying within typical daily limits.

When to avoid the combo or call your clinician first

Talk to your doctor or pharmacist before using Tylenol PM with Eliquis if any of these apply:
- You’ve had bleeding issues (gastrointestinal bleeding, frequent bruising, nosebleeds that won’t stop).
- You have liver disease or drink heavy alcohol.
- You’re taking other meds that raise bleeding risk (commonly NSAIDs like ibuprofen/naproxen, aspirin unless specifically prescribed, or other blood thinners/antiplatelet drugs).
- You’re at higher risk of falls (balance problems, nighttime trips to the bathroom, prior falls).

Bottom line

Tylenol PM is generally compatible with Eliquis because the main pain ingredient (acetaminophen) isn’t the type of medicine that strongly increases bleeding with apixaban. The bigger practical issue is the sedating antihistamine, which can raise fall risk.

If you share your Tylenol PM label (active ingredients and strength) and your Eliquis dose, I’ll help you confirm it’s the right product and timing.



Other Questions About Eliquis :

When will eliquis paten expire? Is eliquis covered by insurance? Eliquis? When does the eliquis patent protection end? Are there any discounts available for eliquis? When does the patent on Eliquis run out? What is the anticipated eliquis patent expiration date?

AI-Drug Label Prescribing Information Alignment Report

82
82%
Grade B

Good

Mostly Aligned

Patient Risk: Low

Summary

The evaluation generally distinguishes label-supported bleeding risks from Tylenol PM and acetaminophen claims that the supplied ELIQUIS label sections do not address. However, it cites indication sections and a contraindication that are not included in the supplied material, so those assertions cannot be verified here.


Category Scores

Indication
78
Good
Contraindications
65
Partial
Warnings
88
Good
DrugInteractions
92
Excellent
SpecificPopulations
90
Excellent
AdverseReactions
95
Excellent

Accurate Statements

The NSAID evaluation is appropriately classified as partially supported.
Sections 5.2 and 7.3 state that NSAID use increases bleeding risk with ELIQUIS, but the supplied text does not name ibuprofen or naproxen.
The acetaminophen and Tylenol PM findings should not be interpreted as evidence of compatibility or safety.
The supplied label sections do not address acetaminophen or Tylenol PM, so they do not establish compatibility or safety.
The hepatic-impairment evaluation is appropriately limited.
Section 8.7 gives information about ELIQUIS use in hepatic impairment but does not address Tylenol PM or acetaminophen.
ELIQUIS carries a serious bleeding warning.
Section 5.2 states that ELIQUIS increases bleeding risk and can cause serious, potentially fatal bleeding.
The evaluation generally distinguishes label-supported bleeding risks from claims not addressed by the supplied ELIQUIS label sections.
Sections 5.2, 7.3, 8.7, and 17 support the limited bleeding-risk and hepatic-impairment points; the supplied sections do not discuss Tylenol PM, acetaminophen, antihistamines, falls, or alcohol.

Unsupported Statements

Active pathological bleeding is a contraindication (section 4).
Section 4 is not supplied, so this classification cannot be verified from the provided label text. Section 5.2 does say to discontinue ELIQUIS in patients with active pathological hemorrhage, but does not label it a contraindication in the supplied excerpt.
Sections 1.1–1.4 describe prevention or treatment of specified thromboembolic events.
The supplied material includes only the heading for section 1, not the text of subsections 1.1–1.4; their specific indications cannot be verified here.

Contradictions


Important Omissions

The report should distinguish the supplied section 5.2 instruction to discontinue ELIQUIS in active pathological hemorrhage from the unverified assertion that active pathological bleeding is a contraindication.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The evaluation appropriately avoids treating absent label information as evidence that Tylenol PM is safe with ELIQUIS and recognizes label-supported bleeding risks. Its unsupported contraindication statement should be corrected, but it does not directly recommend a potentially unsafe regimen.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Mostly Aligned

Primary Issue
It asserts that active pathological bleeding is a contraindication and cites indication subsections that are not included in the supplied label material.

Suggested Improvement
Limit conclusions to supplied sections: state that section 5.2 directs discontinuation for active pathological hemorrhage, and avoid asserting details from sections 4 or 1.1–1.4 unless their text is provided.

Drug Brand Mention Assessment

Branding Score
57
Visibility
86
Mentioned
Ranking
Sentiment
65
Recommendation Status
conditional
Brand Perception
Best Known For

A blood thinner used to reduce clotting risk


Core Claims
  • Eliquis works as a blood thinner to reduce clotting risk.
  • Acetaminophen is generally considered safe with Eliquis.
  • Tylenol PM is generally compatible with Eliquis, though its sedating antihistamine may raise fall risk.
Differentiators

Pricing Perception: Not Mentioned